↓ Skip to main content

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

Overview of attention for article published in BMC Cancer, December 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
Published in
BMC Cancer, December 2018
DOI 10.1186/s12885-018-5134-7
Pubmed ID
Authors

Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, Emilio Sacco, Pier Francesco Bassi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Researcher 7 10%
Other 7 10%
Student > Master 5 7%
Student > Ph. D. Student 4 6%
Other 12 17%
Unknown 25 36%
Readers by discipline Count As %
Medicine and Dentistry 26 37%
Biochemistry, Genetics and Molecular Biology 3 4%
Unspecified 2 3%
Agricultural and Biological Sciences 2 3%
Immunology and Microbiology 1 1%
Other 3 4%
Unknown 33 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2019.
All research outputs
#20,588,763
of 23,175,240 outputs
Outputs from BMC Cancer
#6,562
of 8,405 outputs
Outputs of similar age
#372,446
of 437,380 outputs
Outputs of similar age from BMC Cancer
#160
of 208 outputs
Altmetric has tracked 23,175,240 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,405 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,380 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 208 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.